Page last updated: 2024-08-23

cefoperazone and Pneumonia, Staphylococcal

cefoperazone has been researched along with Pneumonia, Staphylococcal in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu	1
Alekseev, VV; Khrapova, NP; Rotov, KA; Simakova, NA; Snatenkov, EA; Tikhonov, SN; Zamarin, AA	1
Hara, K; Higashiyama, Y; Koga, H; Kohno, S; Maesaki, S; Matsuda, H; Mitsutake, K; Miyazaki, Y; Yamada, H; Yoshitomi, Y	1

Trials

1 trial(s) available for cefoperazone and Pneumonia, Staphylococcal

Article	Year
[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:12 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome	2003

Article

Year

[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:12

Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome

2003

Other Studies

2 other study(ies) available for cefoperazone and Pneumonia, Staphylococcal

Article	Year
[Experimental study on the therapeutic effect of liposome-entrapped antibiotics in the treatment of destructive pneumonia]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2005, Volume: 50, Issue:8-9 Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Female; Gentamicins; Liposomes; Male; Mice; Mice, Inbred Strains; Pneumonia, Staphylococcal	2005
Fatal pneumonia caused by Corynebacterium group JK after treatment of Staphylococcus aureus pneumonia. Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:7 Topics: Aged; Cefoperazone; Corynebacterium; Corynebacterium Infections; Disease Susceptibility; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Minocycline; Opportunistic Infections; Pneumonia; Pneumonia, Staphylococcal; Sulbactam	1992

Article

Year

[Experimental study on the therapeutic effect of liposome-entrapped antibiotics in the treatment of destructive pneumonia].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2005, Volume: 50, Issue:8-9

Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Female; Gentamicins; Liposomes; Male; Mice; Mice, Inbred Strains; Pneumonia, Staphylococcal

2005

Fatal pneumonia caused by Corynebacterium group JK after treatment of Staphylococcus aureus pneumonia.

Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:7

Topics: Aged; Cefoperazone; Corynebacterium; Corynebacterium Infections; Disease Susceptibility; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Minocycline; Opportunistic Infections; Pneumonia; Pneumonia, Staphylococcal; Sulbactam

1992